CIAM
MBOT icon

Caitong International Asset Management’s Microbot Medical MBOT Stock Holding History

Caitong International Asset Management’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86.4K Buy
35,862
+3,266
+10% +$7.29K 0.02% 624
2025
Q4 		$65.2K Buy
+32,596
New +$77.2K 0.02% 602
2025
Q3 		– Sell
-3,273
Closed -$8.25K – 2278
2025
Q2 		$8.25K Buy
3,273
+3,228
+7,173% +$7.72K 0.01% 802
2025
Q1 		$68 Buy
+45
New +$80 ﹤0.01% 2017

Other funds holding MBOT

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Caitong International Asset Management's MBOT Position: Q1 2026 in Review

Caitong International Asset Management increased its Microbot Medical (MBOT) stake by 10% in Q1 2026, buying an estimated $7.29K and bringing the position to 35,862 shares worth $86.4K. The position accounts for 0.02% of the portfolio, ranked #624.

Caitong International Asset Management first reported a position in MBOT in Q1 2025 and has held it in 4 quarters since. 79 funds tracked by Wall St. Rank hold MBOT as of Q1 2026.

  • Caitong International Asset Management held 35,862 shares of Microbot Medical worth $86.4K as of Q1 2026.
  • Caitong International Asset Management bought 3,266 Microbot Medical shares in Q1 2026, an estimated $7.29K.
  • Microbot Medical made up 0.02% of Caitong International Asset Management's portfolio in Q1 2026, its #624 holding.
  • Caitong International Asset Management first reported a position in Microbot Medical in Q1 2025 and has held it in 4 quarters since.
  • 79 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.